Thrombelastography rotational (ROTEM®) utility for monitoring patients with haemophilia and factor VIII inhibitors treated with rFVIIa (NOVOSEVEN®)

被引：0
|
作者：
Garcia-Rodriguez, M. [1 ]
Alvarez, M. [1 ]
Martin-Salces, M. [1 ]
Fernandez, I [1 ]
Butta, N. [1 ]
Rivas, I [1 ]
Munoz, I [1 ]
Jimenez-Yuste, V [1 ]
Hernandez-Navarro, F. [1 ]
机构：
[1] Hosp La Paz, Hematol, Madrid, Spain
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-TH-604
引用
收藏
页码：1135 / 1135
页数：1
相关论文
共 50 条
  • [31] Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors
    Reipert, Birgit M.
    van den Helden, Patiline M. W.
    Schwarz, Hans-Peter
    Hausl, Christina
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (01) : 12 - 25
  • [32] Cross-reactivity to porcine factor VIII of factor VIII inhibitors in patients with haemophilia in Australia and New Zealand
    Lloyd, JV
    Street, AM
    Berry, E
    McPherson, J
    Ekert, H
    Lammi, A
    McWhirter, WR
    Duncan, EM
    Maxwell, EL
    Rowell, J
    Baker, RI
    Leahy, MF
    Jupe, D
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1997, 27 (06): : 658 - 664
  • [33] Glycopegylated long acting factor VIIA and rFVIIA (Novoseven®) show similar efficacy in blood from haemophilia A patients using thromboelastograph (TEG®)
    Christiansen, M.
    Sorensen, B.
    Viuff, D.
    Ezban, M.
    Andersen, S.
    Lethagen, S.
    HAEMOPHILIA, 2010, 16 : 34 - 35
  • [34] Factor VIII inhibitors in previously treated hemophilic patients
    Mannucci, P. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (11) : 2328 - 2329
  • [35] Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A
    Mauser-Bunschoten, EP
    van der Bom, JG
    Bongers, M
    Twijnstra, M
    Roosendaal, G
    Fischer, K
    van den Berg, HM
    HAEMOPHILIA, 2001, 7 (04) : 364 - 368
  • [36] Factor VIII inhibitors in patients with congenital severe haemophilia A and its relation to genotype
    Pio, S. F.
    Ozelo, M. C.
    Dos Santos, A.
    De Carvalho, B. V.
    Caram, C.
    Zouain, D.
    Oliveira, G. C.
    Rezende, S. M.
    HAEMOPHILIA, 2012, 18 (06) : e411 - e414
  • [37] Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors
    Unuvar, A
    Warrier, I
    Lusher, JM
    HAEMOPHILIA, 2000, 6 (03) : 150 - 157
  • [38] FACTOR-VIII INHIBITORS AND USE OF BLOOD PRODUCTS IN PATIENTS WITH HAEMOPHILIA-A
    IKKALA, E
    SIMONEN, O
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1971, 8 (01): : 16 - &
  • [39] Factor VIII-specific B cell responses in haemophilia A patients with inhibitors
    Van Helden, P. M. W.
    Van Haren, S. D.
    Fijnvandraat, K.
    Van Den Berg, H. Marijke
    Voorberg, J.
    HAEMOPHILIA, 2010, 16 : 35 - 43
  • [40] Cost-utility analysis of recombinant factor VIIa (NovoSeven®) in six children with long-standing inhibitors to factor VIII or IX
    Ekert, H
    Brewin, T
    Boey, W
    Davey, P
    Tilden, D
    HAEMOPHILIA, 2001, 7 (03) : 279 - 285
12345